January 9, 2026 Mabqi & Syndivia announce the execution of an exclusive licensing agreement for their jointly discovered ADC Read more »
November 6, 2025 Mabqi and Abzena announce strategic partnership covering Discovery to Development Read more »
October 23, 2025 Redefining the future of antibody discovery with LiteMab Antibody Discovery Studio Read more »
February 26, 2025 Mabqi secures a €5 million funding for lead antibody candidate MQI-201 from France 2030 Read more »
